Kaneko Yasunori
SEC-identified person · CIK 1277503 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arcus Biosciences, Inc. RCUS | Director | filed 2018 - 2026 |
| SI-Bone, Inc. SIBN | Officer | filed 2018 - 2018 |
| Sutro Biopharma, INC. STRO | Officer | filed 2018 - 2018 |
| Collegium Pharmaceutical, INC COLL | Officer | filed 2015 - 2017 |
| Merrill Corp /NEW/ - FA COLL | Officer | filed 2015 - 2015 |
| Dicerna Pharmaceuticals Inc DRNA | Officer | filed 2014 - 2015 |
| Protara Therapeutics, Inc. TARA | Officer | filed 2014 - 2014 |
| Tetraphase Pharmaceuticals INC TTPH | Officer | filed 2013 - 2014 |
| Talphera, INC. TLPH | Officer | filed 2011 - 2014 |
| Concert Pharmaceuticals, INC. N/A | Officer | filed 2014 - 2014 |
| Targanta Therapeutics Corp. TARG | Officer | filed 2007 - 2009 |
| Hansen Medical INC HNSN | Officer | filed 2006 - 2007 |
| Renovis INC RNVS | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.